Stay updated on Pembrolizumab Combos in mCRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.

Latest updates to the Pembrolizumab Combos in mCRC Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content and blocking access to the NCT03374254 details.SummaryDifference23%

- Check27 days agoChange DetectedThe study page now shows a newer revision tag (v3.7.0), indicating the page was updated to the latest version.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check62 days agoChange DetectedUpdated the page revision label from v3.6.4 to v3.6.5 to reflect a new build; this is a small, informational update with no changes to the study details.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, signaling a site software update. No study content or user-facing data were changed as part of this update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combos in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.